18.11.2009 Boehringer Ingelheim and GlaxoSmithKline back EFA`s call for urgent improvements in care for people with lung disease this World COPD Day 16.11.2009 Flibanserin demonstrates efficacy and tolerability in pivotal Phase III Trials in pre-menopausal women with Hypoactive Sexual Desire Disorder (HSDD) For medical media, outside the US only 02.11.2009 Boehringer Ingelheim announces record productivities for CHO cells using the BI-HEX technology platform 29.10.2009 Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products 26.10.2009 Boehringer Ingelheim Animal Health closes deal to acquire a significant portion of the Fort Dodge Animal Health Business from Pfizer For medical media, outside the US only 23.10.2009 CHMP issues positive opinion for Micardis<sup>®</sup> (telmisartan) as the first treatment in its class to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients For medical media, outside the US only 19.10.2009 FDA approves Micardis<sup>®</sup> (telmisartan) as the first treatment in its class to reduce the risk of heart attack, stroke, or death from cardiovascular causes in patients at high cardiovascular risk who are unable to take ACE inhibitors For medical media, outside the US only 19.10.2009 FDA approves Twynsta<sup>®</sup> (telmisartan plus amlodipine) a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours For medical media, outside the US only 14.10.2009 Boehringer Ingelheim receives approval from the European Commission for Mirapexin<sup>®</sup>/Sifrol<sup>®</sup> prolonged-release, once daily tablet for the treatment of Parkinson`s disease For medical media, outside the US only 07.10.2009 Access to HIV medication